Live Breaking News & Updates on Jones research

Stay informed with the latest breaking news from Jones research on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Jones research and stay connected to the pulse of your community

Aptose Biosciences Inc. (NASDAQ:APTO) Q4 2023 Earnings Call Transcript

Operator: Good afternoon. My name is Jonathan and I will be your conference operator today.

Japan , Canada , Canadian , Soumit-roy , Aptose-biosciences , Susan-pietropaolo , William-rice , Rafael-bejar , Fletcher-payne , Nasdaq , Md-anderson-cancer-center , Aptose-biosciences-inc

Oncolytics Biotech Inc. (NASDAQ:ONCY) Q4 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to Oncolytics Biotech's Fourth Quarter and Full Year 2023 Conference Call. All participants are now in a listen-only mode.

Germany , San-diego , California , United-states , Canada , German , Canadian , American , Louise-chen , John-newman , Matt-coffey , Patrick-trucchio

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript

Anavex Life Sciences Corp. (NASDAQ:AVXL) Q1 2024 Earnings Call Transcript February 7, 2024 Anavex Life Sciences Corp. beats earnings expectations. Reported EPS is $-0.0001, expectations were $-0.14. AVXL isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. Welcome to […]

United-states , Sandra-boenisch , Christopher-missling , Soumit-roy , Jones-research , Trademark-office , Food-effect , Receptor-agonist , Frontotemporal-dementia , United-states-patent , Principal-financial-officer , Quality-egg-brands

Arcutis Stock: Slow Sales Of Zoryve May Be Painting The Wrong Picture (NASDAQ:ARQT)

Arcutis Stock: Slow Sales Of Zoryve May Be Painting The Wrong Picture (NASDAQ:ARQT)
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

California , United-states , Westlake-village , Frank-watanabe , Ducentis-biotherapeutics , Roivant-sciences , Anacor-pharmaceuticals , Jones-research , Incyte-corporation , Intercontinental-exchange-benchmark-administration-ltd , Drug-agency , Investment-corp

Seeking up to 9% Dividend Yield? Here Are 2 Dividend Stocks Billionaire Bill Miller Is Holding for Income Growth

The markets have been exhibiting some wobbly tendencies recently, with the strong rally seen in the first half of the year appearing to have wilted a bit under the summer sun. Fear not, however, appears to be the advice of one prominent stock picker. With US inflation falling to 3% recently compared to last summer’s 9%, and with GDP growth in the last quarter coming in at 2.4%, famous value investor Bill Miller, whose net worth is valued at $1.4 billion, thinks the rest of the year looks pretty

Texas , United-states , Virginia , Florida , Georgia , Michigan , Matthew-erdner , Suneet-kamath , Bill-miller , Jones-research , Alpine-income-property , Realty-growth

Seeking up to 8% Dividend Yield? Analysts Suggest 2 Dividend Stocks to Buy

The strong year-to-date gains in the stock market are impossible to deny, but August’s losses serve as a reminder that investors need to have a cautionary plan for tougher times. Furthermore, according to strategists from JPMorgan and Wells Fargo, these challenging times may be closer than we think. The gains have largely been powered by the AI boom in tech – and that has led to an unstable situation, with rising stock indexes resting on a narrow base. According to JPMorgan’s Chief Global Market

Delaware , United-states , Texas , Marie-ferguson , Scott-wren , Eduardo-seda , Crown-castle , Marko-kolanovic , Wells-fargo , Jones-research , Kinetik-holdings , Chief-global-market-strategist-marko-kolanovic

Plus Therapeutics Announces Key Opinion Leader Roundtable on New Clinical Trial Data Being Presented at the 2023 SNO/ASCO CNS Cancer Conference

Trial investigators and company management to discuss latest data from the ReSPECT-LM leptomeningeal metastases clinical trial Webinar scheduled for Friday, August 11, 2023 at 8:00 a.m. ET AUSTIN,...

San-antonio , Texas , United-states , University-of-texas , American , Peter-vozzo , Priya-kumthekar , Justin-walsh , March-hedrick , Andrewj-brenner , Terri-clevenger , Exchange-commission

Plus Therapeutics Announces Key Opinion Leader Roundtable

Trial investigators and company management to discuss latest data from the ReSPECT-LM leptomeningeal metastases clinical trial Webinar scheduled for...

University-of-texas , Texas , United-states , San-antonio , American , March-hedrick , Justin-walsh , Andrewj-brenner , Priya-kumthekar , Terri-clevenger , Peter-vozzo , Jones-research

Plus Therapeutics Announces Key Opinion Leader Roundtable on New Clinical Trial Data Being Presented at the 2023 SNO/ASCO CNS Cancer Conference

Plus Therapeutics Announces Key Opinion Leader Roundtable on New Clinical Trial Data Being Presented at the 2023 SNO/ASCO CNS Cancer Conference
itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.

Texas , United-states , University-of-texas , San-antonio , American , Andrewj-brenner , Terri-clevenger , Justin-walsh , March-hedrick , Peter-vozzo , Priya-kumthekar , Exchange-commission

These 12%-Yielding Dividend Stocks Look Very Attractive Right Now, Analysts Say

The markets have been hot these past six months. The pace of inflation is cooling off, the Federal Reserve is expected to dial back its own pace of interest rate hikes, tech stocks are booming on the strength of AI, and in all, the S&P gave five consecutive months of gains through the end of July. But did we just see a black swan? Fitch cut the US government’s credit rating yesterday, from AAA to AA+, saying that the Federal government’s fiscal situation is likely to deteriorate significantly ov

White-house , District-of-columbia , United-states , Aaron-hecht , Matthew-erdner , Jones-research , Federal-reserve , Hecht , Wall-street , Dynex-capital , Atlantic-real-estate-finance , Chicago-atlantic